| Q40628732 | A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient |
| Q33956020 | A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient |
| Q35050702 | Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production |
| Q38963000 | Analysis of JC virus DNA replication using a quantitative and high-throughput assay. |
| Q27468945 | BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency |
| Q35685505 | Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate |
| Q37730228 | Causality in acute encephalitis: defining aetiologies |
| Q33908200 | Cerebellar Dysfunction in a Patient with HIV |
| Q51846870 | Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis. |
| Q34735441 | Detection of JC virus-specific immune responses in a novel humanized mouse model |
| Q92473906 | Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain |
| Q40039520 | Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies |
| Q34032491 | Frequency and large T (LT) sequence of JC polyomavirus DNA in oligodendrocytes, astrocytes and granular cells in non-PML brain. |
| Q35634870 | Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy |
| Q38394692 | Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitis |
| Q42561798 | Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter |
| Q38019772 | HIV-associated opportunistic infections of the CNS. |
| Q35314514 | Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature |
| Q42701998 | Human Polyomavirus-Associated Cerebral Disorders in the Post-HAART Era |
| Q35931809 | Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. |
| Q104568119 | Infections de l’immunodéprimé (hors VIH): Infections (HIV patients excluded) in immunosuppressed patients |
| Q37766302 | Inflammation in neurodegenerative diseases |
| Q37198798 | Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis |
| Q28552120 | JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection |
| Q60696889 | JC Virus Infection: An Expanding Spectrum of Neurological Disorders |
| Q38379787 | JC Virus Infects Neurons and Glial Cells in the Hippocampus |
| Q34247539 | JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant |
| Q34043640 | JC virus granular neuronopathy and rhombencephalic progressive multifocal leukoencephalopathy: case report and review of the literature |
| Q35960471 | JC virus granule cell neuronopathy is associated with VP1 C terminus mutants |
| Q45377474 | JC virus infection of the brain |
| Q34120183 | JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy |
| Q35108294 | JC virus nucleotides 376-396 are critical for VP1 capsid protein expression |
| Q35709154 | JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression |
| Q35864067 | Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System |
| Q39391443 | Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis |
| Q41745436 | MRI pattern in asymptomatic natalizumab-associated PML. |
| Q24619923 | Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain |
| Q33754882 | Natalizumab in Multiple Sclerosis: Long-Term Management |
| Q35736438 | Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study |
| Q26781389 | Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities |
| Q34472405 | Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area |
| Q30613846 | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section |
| Q30245002 | Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals. |
| Q38577593 | Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). |
| Q37885823 | Progressive multifocal leukoencephalopathy and natalizumab |
| Q33893285 | Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis |
| Q33763351 | Progressive multifocal leukoencephalopathy and other forms of JC virus disease |
| Q37750534 | Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease |
| Q102220458 | Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease |
| Q37663449 | Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman |
| Q37755922 | Progressive multifocal leukoencephalopathy: what's new? |
| Q36175401 | Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques |
| Q50043312 | Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus. |
| Q38115572 | The human JC polyomavirus (JCPyV): virological background and clinical implications |
| Q26991740 | Viruses and neurodegeneration |